DGAP-Ad-hoc: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Dividend Eckert & Ziegler to Recommend Dividend Payment 20-March-2018 / 20:09 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Eckert & Ziegler Increases Dividend Berlin, 20 March 2018. Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a specialist for isotope-based applications in medicine, science and industry achieved sales of approx. 144.8 million EUR in the fiscal year 2017. As the Supervisory Board stated at its balance sheet meeting, the net profit was 14.7 million EUR or 2.78 EUR per share. The expectations for the fiscal year 2017 were met. Without discontinued operations sales achieved 138.6 million EUR, net profit 11.6 million EUR and earnings per share 2.19 EUR. At the General Shareholders' Meeting to be held on 30 May 2018, the Executive Board and the Supervisory Board will propose a dividend of 0.80 EUR per share entitled to a dividend (previous year: 0.66 EUR per share). The income statement, balance sheet and cash flow statement for the past fiscal year can be found on March 22, 2018 at https://www.ezag.com/home/investors/reports/ The audited annual financial statements will be posted there on March 29, 2018. For enquiries please contact: Eckert & Ziegler AG, Karolin Riehle, Investor Relations Robert-Rössle-Str. 10, 13125 Berlin, Germany Tel.: +49 (0) 30 / 94 10 84-138, [email protected], www.ezag.com --------------------------------------------------------------------------- 20-March-2018 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: Eckert & Ziegler Strahlenund Medizintechnik AG Robert-Rössle-Str.10 13125 Berlin Germany Phone: 49 30 941084-138 Fax: 49 30 941084-112 E-mail: [email protected] Internet: www.ezag.de ISIN: DE0005659700 WKN: 565970 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange End of Announcement DGAP News Service --------------------------------------------------------------------------- 666467 20-March-2018 CET/CEST